These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 7888051)

  • 1. Renal allograft rejection: the temporal relationship and predictive value of plasma TNF (alpha and beta), IFN-gamma and soluble ICAM-1.
    Kutukculer N; Shenton BK; Clark K; Rigg KM; Forsythe JL; Kirby JA; Proud G; Taylor RM
    Transpl Int; 1995; 8(1):45-50. PubMed ID: 7888051
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serial measurements of interleukin-6, interleukin-8, tumor necrosis factor-alpha, and soluble vascular cell adhesion molecule-1 in the peripheral blood plasma of human cardiac allograft recipients.
    George JF; Kirklin JK; Naftel DC; Bourge RC; White-Williams C; McGiffin DC; Savunen T; Everson MP
    J Heart Lung Transplant; 1997 Oct; 16(10):1046-53. PubMed ID: 9361247
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Renal allograft rejection: induction and function of adhesion molecules on cultured epithelial cells.
    Lin Y; Kirby JA; Clark K; Shenton BK; Forsythe JL; Proud G; Taylor RM
    Clin Exp Immunol; 1992 Oct; 90(1):111-6. PubMed ID: 1382902
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Soluble adhesion molecules in renal transplantation.
    Bricio T; Rivera M; Molina A; Martin A; Burgos J; Mampaso F
    Ren Fail; 1996 Jan; 18(1):75-83. PubMed ID: 8820503
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatic allograft rejection is associated with increased levels of soluble intercellular adhesion molecule-1.
    Ninova D; Krom RA; Wiesner RH
    Liver Transpl Surg; 1995 Sep; 1(5):290-5. PubMed ID: 9346585
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Production of cytokines (TNF-alpha, IL-1-beta) and endothelial cell activation in human liver allograft rejection.
    Hoffmann MW; Wonigeit K; Steinhoff G; Herzbeck H; Flad HD; Pichlmayr R
    Transplantation; 1993 Feb; 55(2):329-35. PubMed ID: 8094579
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Soluble FGL2 induced by tumor necrosis factor-α and interferon-γ in CD4+ T cells through MAPK pathway in human renal allograft acute rejection.
    Zhao Z; Wang L; Yang C; Zhao T; Li L; Hu L; Wu D; Rong R; Xu M; Zhu T
    J Surg Res; 2013 Oct; 184(2):1114-22. PubMed ID: 23664593
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lack of Association Between Elevated Urinary Levels of Interleukin-10 and Interferon Gamma With the Presence of Inflammation in Kidney Transplant Recipients.
    García-Covarrubias L; Ventura E; Soto V; González E; García A; Aguilar JC; Torres JM; Hinojosa H; Fragoso P; De Los Santos J; Ortuño D; San Cristóbal P; Díliz H
    Transplant Proc; 2016 Mar; 48(2):583-7. PubMed ID: 27110008
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunomodulatory effect of pentoxifylline during human allograft rejection: involvement of tumor necrosis factor-alpha and adhesion molecules.
    Noel C; Copin MC; Hazzan M; Labalette M; Susen S; Lelievre G; Dessaint JP
    Transplantation; 2000 Mar; 69(6):1102-7. PubMed ID: 10762214
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of TH1/TH2 cytokines in kidney allograft rejection.
    Karczewski J; Karczewski M; Glyda M; Wiktorowicz K
    Transplant Proc; 2008 Dec; 40(10):3390-2. PubMed ID: 19100396
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Soluble cell adhesion molecules in chronic renal graft rejection].
    Boratyńska M
    Pol Arch Med Wewn; 1998 Nov; 100(5):410-8. PubMed ID: 10410574
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Th1/Th2 cytokines and ICAM-1 levels post-liver transplant do not predict early rejection.
    Granot E; Tarcsafalvi A; Emre S; Sheiner P; Guy S; Schwartz ME; Boros P; Miller CM
    Mediators Inflamm; 2000; 9(1):35-8. PubMed ID: 10877453
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Soluble intercellular adhesion molecule-1 (sICAM-1) after kidney transplantation: the origin and role of urinary sICAM-1?
    Teppo AM; von Willebrand E; Honkanen E; Ahonen J; Grönhagen-Riska C
    Transplantation; 2001 Apr; 71(8):1113-9. PubMed ID: 11374412
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TNF-alpha, IL-6, IFN-gamma, and IL-10 gene expression polymorphisms and the IL-4 receptor alpha-chain variant Q576R: effects on renal allograft outcome.
    Hahn AB; Kasten-Jolly JC; Constantino DM; Graffunder E; Singh TP; Shen GK; Conti DJ
    Transplantation; 2001 Aug; 72(4):660-5. PubMed ID: 11544427
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of cell adhesion molecules in primary renal disease and renal allograft rejection.
    Hauser IA; Riess R; Hausknecht B; Thüringer H; Sterzel RB
    Nephrol Dial Transplant; 1997 Jun; 12(6):1122-31. PubMed ID: 9198039
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multiple-biomarkers provide powerful prediction of early acute renal allograft rejection by combination of serum fractalkine, IFN-γ and IP-10.
    Xu CX; Shi BY; Jin ZK; Hao JJ; Duan WL; Han F; Zhao YL; Ding CG; Xue WJ; Ding XM; Zheng J; Tian PX
    Transpl Immunol; 2018 Oct; 50():68-74. PubMed ID: 30081186
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytokine gene polymorphisms in kidney transplantation.
    Dhaouadi T; Sfar I; Bardi R; Jendoubi-Ayed S; Abdallah TB; Ayed K; Gorgi Y
    Transplant Proc; 2013; 45(6):2152-7. PubMed ID: 23747182
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Posttransplant peripheral blood donor-specific interferon-γ enzyme-linked immune spot assay differentiates risk of subclinical rejection and de novo donor-specific alloantibodies in kidney transplant recipients.
    Crespo E; Cravedi P; Martorell J; Luque S; Melilli E; Cruzado JM; Jarque M; Meneghini M; Manonelles A; Donadei C; Lloberas N; Gomà M; Grinyó JM; Heeger P; Bestard O
    Kidney Int; 2017 Jul; 92(1):201-213. PubMed ID: 28274484
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum circulating ICAM-1 levels are not useful to indicate active vasculitis or early renal allograft rejection.
    John S; Neumayer HH; Weber M
    Clin Nephrol; 1994 Dec; 42(6):369-75. PubMed ID: 7882600
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumor necrosis factor production during human renal allograft rejection is associated with depression of plasma protein C and free protein S levels and decreased intragraft thrombomodulin expression.
    Tsuchida A; Salem H; Thomson N; Hancock WW
    J Exp Med; 1992 Jan; 175(1):81-90. PubMed ID: 1309855
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.